Sex differences in incidence of self-reported adverse drug reactions after percutaneous coronary intervention
Pettersen T, Schjott J, Allore H, Bendz B, Borregaard B, Fridlund B, Hadjistavropoulos H, Larsen A, Nordrehaug J, Rasmussen T, Rotevatn S, Valaker I, Wentzel-Larsen T, Norekval T. Sex differences in incidence of self-reported adverse drug reactions after percutaneous coronary intervention. European Heart Journal 2023, 44: ehad655.2879. DOI: 10.1093/eurheartj/ehad655.2879.Peer-Reviewed Original ResearchSelf-reported adverse drug reactionsPercutaneous coronary interventionAdverse drug reactionsPotential adverse drug reactionsPrescribed therapyCoronary interventionHospital dischargeDrug reactionsMedical recordsOdds ratioIncidence of ADRsProspective multicentre cohort studyMore adverse drug reactionsMulticentre cohort studyAcute coronary syndromeSex differencesTotal study populationConfidence intervalsPatients' medical recordsClinical drug trialsProportion of womenHeart ContinuityCoronary syndromeCohort studyPCI center